HUE036183T2 - JC Vírus antitestekre vonatkozó assay - Google Patents

JC Vírus antitestekre vonatkozó assay

Info

Publication number
HUE036183T2
HUE036183T2 HUE11732315A HUE11732315A HUE036183T2 HU E036183 T2 HUE036183 T2 HU E036183T2 HU E11732315 A HUE11732315 A HU E11732315A HU E11732315 A HUE11732315 A HU E11732315A HU E036183 T2 HUE036183 T2 HU E036183T2
Authority
HU
Hungary
Prior art keywords
assay
virus
virus assay
assay assay
Prior art date
Application number
HUE11732315A
Other languages
English (en)
Inventor
Leonid Gorelik
Kenneth Simon
Meena Subramanyam
Mia Rushe
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44305841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE036183(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of HUE036183T2 publication Critical patent/HUE036183T2/hu

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HUE11732315A 2010-01-11 2011-01-11 JC Vírus antitestekre vonatkozó assay HUE036183T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29404810P 2010-01-11 2010-01-11
US31619310P 2010-03-22 2010-03-22

Publications (1)

Publication Number Publication Date
HUE036183T2 true HUE036183T2 (hu) 2018-06-28

Family

ID=44305841

Family Applications (3)

Application Number Title Priority Date Filing Date
HUE17203178A HUE060312T2 (hu) 2010-01-11 2011-01-11 A JC vírus antitestek vizsgálata
HUE11732315A HUE036183T2 (hu) 2010-01-11 2011-01-11 JC Vírus antitestekre vonatkozó assay
HUE22191259A HUE070903T2 (hu) 2010-01-11 2011-01-11 A JC vírus antitestek vizsgálata

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE17203178A HUE060312T2 (hu) 2010-01-11 2011-01-11 A JC vírus antitestek vizsgálata

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE22191259A HUE070903T2 (hu) 2010-01-11 2011-01-11 A JC vírus antitestek vizsgálata

Country Status (27)

Country Link
US (2) US9316641B2 (hu)
EP (4) EP3339865B9 (hu)
JP (2) JP5946218B2 (hu)
KR (1) KR101877576B1 (hu)
CN (1) CN102906278A (hu)
AU (1) AU2011203815B2 (hu)
BR (1) BR112012017014B1 (hu)
CA (1) CA2784137A1 (hu)
CY (2) CY1119972T1 (hu)
DK (3) DK3339865T5 (hu)
ES (3) ES2664173T3 (hu)
FI (2) FI4152004T3 (hu)
HR (3) HRP20221390T1 (hu)
HU (3) HUE060312T2 (hu)
IN (1) IN2012DN06139A (hu)
LT (3) LT2524060T (hu)
ME (1) ME03026B (hu)
MX (1) MX341991B (hu)
NO (1) NO2524060T3 (hu)
NZ (1) NZ600681A (hu)
PL (3) PL3339865T3 (hu)
PT (3) PT2524060T (hu)
RS (3) RS66509B1 (hu)
SG (2) SG10201500079YA (hu)
SI (3) SI3339865T1 (hu)
SM (3) SMT202500065T1 (hu)
WO (1) WO2011085369A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2640295T5 (en) 2005-04-04 2025-02-13 Biogen Ma Inc Methods for evaluating an immune response to a therapeutic agent
HUE047230T2 (hu) 2006-02-28 2020-04-28 Biogen Ma Inc Gyulladásos és autoimmun betegségek natalizumabbal való kezelésének módszerei
AU2007224228B2 (en) 2006-03-03 2013-09-19 Biogen Ma Inc. Methods of treating inflammatory and autoimmune diseases with natalizumab
WO2011044553A1 (en) 2009-10-11 2011-04-14 Biogen Idec Ma Inc. Anti-vla-4 related assays
PT2524060T (pt) 2010-01-11 2018-03-28 Biogen Ma Inc Ensaio para a deteção de anticorpos contra o vírus jc
US11287423B2 (en) * 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
PT3575792T (pt) * 2011-05-31 2023-02-28 Biogen Ma Inc Método de avaliação do risco de lmp
WO2013087601A2 (en) * 2011-12-12 2013-06-20 Janssen Diagnostics Bvba Polyomavirus peptide sequences
US20130273549A1 (en) * 2012-04-16 2013-10-17 Board Of Regents, The University Of Texas System Detection of extracellular jcv micrornas
US9631243B2 (en) 2012-06-18 2017-04-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for identifying JC virus
CN104936980B (zh) * 2012-12-31 2019-06-07 生物控股有限公司 用于治疗和预防多瘤病毒相关的疾病的重组人抗体
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
EP3004334A4 (en) 2013-05-28 2016-12-21 Biogen Ma Inc METHOD FOR ASSESSING A PML RISK
EP3110976B1 (en) * 2014-02-27 2020-05-13 Biogen MA Inc. Method of assessing risk of pml
MA40985A (fr) 2014-11-17 2017-09-26 Biogen Ma Inc Méthodes de traitement de la sclérose en plaques
IT201600083859A1 (it) * 2016-08-09 2018-02-09 Univ Degli Studi Di Ferrara Immunosaggio per l’identificazione di anticorpi contro il virus Polioma JC (JCPyV) mediante l’uso di peptidi sintetici.
US20210002372A1 (en) * 2018-03-02 2021-01-07 United States Government As Represented By The Department Of Veterans Affairs Methods and compositions for treating natalizumab-associated progressive multifocal encephalopathy

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4235601A (en) 1979-01-12 1980-11-25 Thyroid Diagnostics, Inc. Test device and method for its use
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
US5763262A (en) 1986-09-18 1998-06-09 Quidel Corporation Immunodiagnostic device
ES2150428T3 (es) 1987-04-27 2000-12-01 Unilever Nv Ensayos de union especifica.
US4943522A (en) 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US5120643A (en) 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US4818677A (en) 1987-12-03 1989-04-04 Monoclonal Antibodies, Inc. Membrane assay using focused sample application
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5221616A (en) 1988-07-15 1993-06-22 Quidel Corporation Prevention of spontaneous complement activation in mammalian biological fluids
US5118630A (en) 1988-11-04 1992-06-02 Quidel Corporation Method for determining periodic infertility in females
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US6033665A (en) 1989-09-27 2000-03-07 Elan Pharmaceuticals, Inc. Compositions and methods for modulating leukocyte adhesion to brain endothelial cells
US5084828A (en) 1989-09-29 1992-01-28 Healthtech Services Corp. Interactive medication delivery system
US5252496A (en) 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
US5096837A (en) 1990-02-08 1992-03-17 Pacific Biotech, Inc. Immunochromatographic assay and method of using same
US5223220A (en) 1990-03-27 1993-06-29 Pacific Biotech, Inc. Solid phase immunoassay device and method of making same
US5118428A (en) 1990-11-13 1992-06-02 Quidel Method to remove red blood cells from whole blood samples
DE4139840B4 (de) 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
EP0566695B1 (en) 1991-01-11 1999-06-02 Quidel Corporation A one-step lateral flow assay and nonbibulous support used therein
US5213796A (en) 1991-05-06 1993-05-25 Dana Farber Cancer Institute Assay for polyomavirus in humans and uses thereof
US5225328A (en) 1991-05-30 1993-07-06 Quidel Corporation Stable alkaline phosphatase compositions with color enhancement and their use in assays
US5686315A (en) 1991-06-14 1997-11-11 Quidel Corporation Assay device for one step detection of analyte
WO1993015217A1 (en) 1992-02-04 1993-08-05 Quidel Corporation Simplified extraction method for bacterial antigens using dried reagents
US5541069A (en) 1992-02-28 1996-07-30 Quidel Corporation Assay having improved dose response curve
JP2948318B2 (ja) 1992-03-10 1999-09-13 クイデル コーポレイション 特異的結合アッセイ用の赤血球の分離方法
NZ261259A (en) 1993-01-12 1996-12-20 Biogen Inc Humanised recombinant anti-vla4 antibody and diagnostic compositions and medicaments
US5415994A (en) 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
US5840299A (en) 1994-01-25 1998-11-24 Athena Neurosciences, Inc. Humanized antibodies against leukocyte adhesion molecule VLA-4
US5434057A (en) 1994-02-02 1995-07-18 Quidel Corporation Sperm motility assay and devices
US5521102A (en) 1994-08-08 1996-05-28 Quidel Corporation Controlled sensitivity immunochromatographic assay
US5845255A (en) 1994-10-28 1998-12-01 Advanced Health Med-E-Systems Corporation Prescription management system
US6551593B1 (en) 1995-02-10 2003-04-22 Millennium Pharmaceuticals, Inc. Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
US5712172A (en) 1995-05-18 1998-01-27 Wyntek Diagnostics, Inc. One step immunochromatographic device and method of use
US5804452A (en) 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
US5786220A (en) 1995-04-28 1998-07-28 Quidel Corporation Assays and devices for distinguishing between normal and abnormal pregnancy
US20010051350A1 (en) 1995-05-02 2001-12-13 Albert Nazareth Diagnostic detection device and method
US5773234A (en) 1995-08-07 1998-06-30 Quidel Corporation Method and device for chlamydia detection
DE19543553B4 (de) 1995-11-22 2009-04-09 Deutsches Primatenzentrum Gmbh VP-Antigene des JC-Virus
US6305377B1 (en) 1996-12-12 2001-10-23 Michael T. Portwood System and method for improving compliance of a medical regimen
US6229011B1 (en) 1997-08-22 2001-05-08 Hoffman-La Roche Inc. N-aroylphenylalanine derivative VCAM-1 inhibitors
US6306642B1 (en) 1997-11-24 2001-10-23 Quidel Corporation Enzyme substrate delivery and product registration in one step enzyme immunoassays
US6623981B2 (en) 1998-01-27 2003-09-23 Bristol-Myers Squibb Company Detection of patients at risk for developing integrin antagonist/agonist mediated disease states
US6014631A (en) 1998-04-02 2000-01-11 Merck-Medco Managed Care, Llc Computer implemented patient medication review system and process for the managed care, health care and/or pharmacy industry
US6045501A (en) 1998-08-28 2000-04-04 Celgene Corporation Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
US6407066B1 (en) 1999-01-26 2002-06-18 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US7171371B2 (en) 1999-09-03 2007-01-30 Smg Trust Method and system for providing pre and post operative support and care
EP1232392B2 (de) 1999-10-12 2014-04-02 Oxoid (Ely) Limited Verbessertes verfahren zum nachweis von säure-resistenten bakterien der gattung helicobacter im stuhl
US6388084B1 (en) 1999-12-06 2002-05-14 Hoffmann-La Roche Inc. 4-pyridinyl-n-acyl-l-phenylalanines
JP2003517023A (ja) 1999-12-16 2003-05-20 バイオジェン インコーポレイテッド 中枢神経系の虚血性損傷または出血性損傷を、抗α４インテグリンアンタゴニストを用いて処置する方法
AU4465001A (en) 2000-03-30 2001-10-15 Nippon Kayaku Kabushiki Kaisha Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
US6620626B1 (en) 2000-08-09 2003-09-16 Mission Research Corp. Antigen detection device and method
MY129000A (en) 2000-08-31 2007-03-30 Tanabe Seiyaku Co INHIBITORS OF a4 MEDIATED CELL ADHESION
JP2004511807A (ja) 2000-10-17 2004-04-15 ベッスト−テスト　アンパーツゼルスカブ 体液サンプル中のｒｓウイルスに関連した生物学的細胞の直接的検出のためのアッセイ
US6315720B1 (en) 2000-10-23 2001-11-13 Celgene Corporation Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
US6485460B2 (en) 2001-01-12 2002-11-26 Bracco Diagnostics, Inc. Tamper evident syringe barrel
WO2003016902A1 (en) 2001-08-20 2003-02-27 Proteome Systems Intellectual Property Pty Ltd Diagnostic testing process and apparatus
US7205159B2 (en) * 2001-08-20 2007-04-17 Proteome Systems Intellectual Property Pty Ltd. Diagnostic testing process and apparatus
US6605602B1 (en) 2001-09-28 2003-08-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Method of treating BK virus nephropathy
SI1485127T1 (sl) 2002-02-25 2011-09-30 Elan Pharm Inc Dajanje aktivne snovi za zdravljenje vnetja
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
WO2004001539A2 (en) 2002-06-21 2003-12-31 Mckesson Information Solutions Llc Closed loop medication use system and method
WO2005052567A1 (en) 2003-11-24 2005-06-09 Biogen Idec Ma Inc. Methods for detecting half-antibodies using chip-based gel electrophoresis
JP4672263B2 (ja) 2004-01-27 2011-04-20 デンカ生研株式会社 簡便な検出法、検出装置及び検出キットとその製法
US7419666B1 (en) 2004-02-23 2008-09-02 Massachusetts Eye And Ear Infirmary Treatment of ocular disorders
TWI439284B (zh) 2004-04-09 2014-06-01 艾伯維生物技術有限責任公司 用於治療ＴＮＦα相關失調症之多重可變劑量療法
US20050283385A1 (en) 2004-06-21 2005-12-22 The Permanente Medical Group, Inc. Individualized healthcare management system
MX2007000228A (es) 2004-07-08 2007-03-30 Elan Pharm Inc Antagonistas de vla-4 multivalentes que comprenden porsiones de polietilenglicol.
CA2478458A1 (en) 2004-08-20 2006-02-20 Michael Panzara Treatment of pediatric multiple sclerosis
US20090169477A1 (en) 2004-12-03 2009-07-02 Michael Panzara Delaying or preventing onset of multiple sclerosis
ES2387317T3 (es) 2005-03-03 2012-09-20 Seedlings Life Science Ventures, Llc. Procedimiento de control de riesgos de pacientes en tratamiento con natalizumab
ES2640295T5 (en) 2005-04-04 2025-02-13 Biogen Ma Inc Methods for evaluating an immune response to a therapeutic agent
NZ567270A (en) 2005-09-29 2011-06-30 Elan Pharm Inc Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
KR20080100271A (ko) 2006-02-27 2008-11-14 엘란 파마슈티칼스, 인크. Ｖｌａ-4에 의해 매개되는 백혈구 부착을 억제하는 피리미디닐 술폰아미드 화합물
CA2641160A1 (en) * 2006-02-28 2007-09-07 Elan Pharmaceuticals, Inc. Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
HUE047230T2 (hu) 2006-02-28 2020-04-28 Biogen Ma Inc Gyulladásos és autoimmun betegségek natalizumabbal való kezelésének módszerei
AU2007224228B2 (en) 2006-03-03 2013-09-19 Biogen Ma Inc. Methods of treating inflammatory and autoimmune diseases with natalizumab
DE602007009446D1 (de) * 2006-06-30 2010-11-11 Sumitomo Rubber Ind Gummizusammensetzung für Reifenlauffläche und Reifen mit daraus hergestellter Reifenlauffläche
US20080233150A1 (en) * 2006-11-16 2008-09-25 Gale Smith Respiratory syncytial virus-virus like particle (vlps)
EP1933140B1 (en) 2006-12-11 2011-08-17 AraGen Biotechnology Co. Ltd. Antibody detection method involving an oligonucleotide enhanced collodial gold signal
WO2010090757A1 (en) 2009-02-05 2010-08-12 Biogen Idec Ma Inc. Methods for the detection of jc polyoma virus
CN102326080B (zh) 2009-02-20 2015-08-05 加利福尼亚大学董事会 A+生物标志物的试验
PT2524060T (pt) * 2010-01-11 2018-03-28 Biogen Ma Inc Ensaio para a deteção de anticorpos contra o vírus jc
PT3575792T (pt) 2011-05-31 2023-02-28 Biogen Ma Inc Método de avaliação do risco de lmp

Also Published As

Publication number Publication date
DK3339865T5 (da) 2023-03-20
BR112012017014B1 (pt) 2021-07-20
ES2930469T3 (es) 2022-12-14
EP4524571A2 (en) 2025-03-19
ES2664173T3 (es) 2018-04-18
PL4152004T3 (pl) 2025-03-24
WO2011085369A1 (en) 2011-07-14
PT3339865T (pt) 2022-11-22
CY1119972T1 (el) 2018-12-12
DK3339865T3 (da) 2022-11-28
EP4152004B1 (en) 2024-11-20
MX2012007660A (es) 2012-07-25
HRP20250210T1 (hr) 2025-04-11
SMT202200445T1 (it) 2023-01-13
EP4152004A1 (en) 2023-03-22
EP4524571A3 (en) 2025-06-11
LT2524060T (lt) 2018-03-26
SMT201800148T1 (it) 2018-05-02
RS56977B1 (sr) 2018-05-31
NO2524060T3 (hu) 2018-04-28
LT4152004T (lt) 2025-02-25
HUE060312T2 (hu) 2023-02-28
SI4152004T1 (sl) 2025-04-30
DK2524060T3 (en) 2018-03-12
US9316641B2 (en) 2016-04-19
LT3339865T (lt) 2022-12-12
SG10201500079YA (en) 2015-03-30
HRP20180356T1 (hr) 2018-04-06
RS66509B1 (sr) 2025-03-31
SMT202500065T1 (it) 2025-03-12
HUE070903T2 (hu) 2025-07-28
NZ600681A (en) 2014-10-31
PL3339865T3 (pl) 2022-12-19
BR112012017014A8 (pt) 2018-06-05
SI2524060T1 (en) 2018-05-31
CN102906278A (zh) 2013-01-30
JP2016040557A (ja) 2016-03-24
EP3339865B9 (en) 2022-12-14
ME03026B (me) 2018-10-20
EP4152004B9 (en) 2025-04-09
SG181653A1 (en) 2012-07-30
MX341991B (es) 2016-09-09
US20160187337A1 (en) 2016-06-30
US10444234B2 (en) 2019-10-15
JP5946218B2 (ja) 2016-07-05
PT2524060T (pt) 2018-03-28
CA2784137A1 (en) 2011-07-14
EP3339865B1 (en) 2022-08-24
AU2011203815B2 (en) 2015-11-26
BR112012017014A2 (pt) 2016-04-05
SI3339865T1 (sl) 2023-01-31
PL2524060T3 (pl) 2018-05-30
EP2524060A1 (en) 2012-11-21
EP3339865A1 (en) 2018-06-27
EP2524060B1 (en) 2017-11-29
DK4152004T3 (da) 2025-02-24
FI3339865T5 (fi) 2023-04-15
FI3339865T3 (hu) 2022-11-30
FI4152004T3 (fi) 2025-02-21
AU2011203815A1 (en) 2012-07-05
ES3012733T3 (en) 2025-04-10
PT4152004T (pt) 2025-02-18
KR20120112621A (ko) 2012-10-11
US20130022961A1 (en) 2013-01-24
CY1126069T1 (el) 2023-11-15
HK1255318A1 (en) 2019-08-16
HRP20221390T1 (hr) 2023-01-06
EP2524060A4 (en) 2013-10-09
JP2013516633A (ja) 2013-05-13
KR101877576B1 (ko) 2018-07-12
IN2012DN06139A (hu) 2015-09-18
RS63744B1 (sr) 2022-12-30

Similar Documents

Publication Publication Date Title
BR112013009271A2 (pt) processador de microcanais
DK3339865T5 (da) Assay for jc-virus-antistoffer
HRP20150926T4 (hr) Pripravci u krutom stanju
PT2552242E (pt) Resumo
BR112013006293A2 (pt) arilpirrolidinas pesticidas
BR112012028556A2 (pt) Indóis
DE102011100241A8 (de) Nitridhalbleiterbauteil
CR20130111A (es) Triazina-oxidiazoles
DE10170954T8 (de) Mikrowellendruckgarer
BR112013014665A2 (pt) misturas pesticidas
BR112012024023A2 (pt) Misturas pesticidas
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
EP2608649A4 (en) Materials spreader
EP2586521A4 (en) MICRO MIXER
DE112011101226A5 (de) Linearwegmesssystem
EP2568895A4 (en) DISTRACTER
DE102010038420A8 (de) Reinigungungsvorrichtung
DE112011101333A5 (de) Parkouraufbau
DE112011102711A5 (de) Hydrostataktor
DE102010035554B8 (de) Fußtüröffner
DE102010019119B8 (de) Cuttermesser
EP2583770A4 (en) STRUCTURE ELEMENT
EP2578316A4 (en) PIPETTE
DE112010005518A5 (de) Dichtungsmanchette
CO6801789A2 (es) N-hetarilmetil pirazolilcarboxamidas